Retrospective study of 25 Centers in China-MPBC

The benefit of overall survival from anthracycline-based chemotherapy regimen for patients with metaplastic breast cancer (MpBC) hasn’t been substantiated due to the rarity of MpBC. This study aimed to assess the overall survival disparities between anthracycline-based and non-anthracycline-based regimens and investigate appropriate chemo-regimen for MpBC patients in real world. These scripts were used to analyze and accomplish the study. The dataset used in study was uploaded.